近日，中国国家药品监督管理局批准了卓和药业集团股份有限公司申报的中药1.1类创新药九味止咳口服液上市。这一消息来自中国药闻微信公众号，对于广大呼吸系统疾病患者来说，无疑是一个值得期待的福音。
九味止咳口服液的上市，标志着我国中药创新药研发取得了新的突破。该药在传统中医理论基础上，结合现代科技，筛选出了具有显著止咳作用的九种中药材，经过科学配比和提取工艺，形成了这款具有高效、安全特点的创新药。
据专家介绍，九味止咳口服液具有清热解毒、润肺止咳的功效，适用于治疗急性上呼吸道感染、支气管炎等疾病。与传统止咳药物相比，该药在改善咳嗽症状的同时，还能有效缓解发热、喉咙痛等不适症状，提高了患者的治疗效果和生活质量。
此外，九味止咳口服液在临床试验中表现出了良好的安全性和耐受性，为患者提供了更加安全的治疗选择。据悉，该药的上市将有助于缓解我国当前呼吸系统疾病的治疗压力，为患者带来更多希望。
英文翻译：
The Chinese State Administration of Traditional Chinese Medicine has recently approved the listing of a new traditional Chinese medicine, “Nine Herb Cough Syrup,” developed by Zhuohe Pharmaceutical Group Co., Ltd. This medication, which is based on traditional Chinese medical theories combined with modern technology, consists of nine herbs with significant cough-relieving properties. After scientific formulation and extraction processes, this innovative medicine has demonstrated high efficiency and safety.
Experts say that “Nine Herb Cough Syrup” has the functions of clearing heat, detoxifying, and moistening the lungs to relieve coughs. It is indicated for the treatment of acute upper respiratory tract infections, bronchitis, and other diseases. Compared to traditional cough medications, this drug not only improves cough symptoms but also effectively alleviate additional discomforts such as fever and sore throat, enhancing the therapeutic effect and quality of life for patients.
Furthermore, the clinical trials of “Nine Herb Cough Syrup” have shown good safety and tolerability, offering patients a safer treatment option. It is reported that the listing of this medicine will help alleviate the current treatment pressures for respiratory diseases in China, bringing more hope to patients.
【来源】http://www.chinanews.com/life/2024/02-21/10167126.shtml
Views: 1